Citigroup
CRBU icon

Citigroup’s Caribou Biosciences CRBU Stock Holding History

Citigroup’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$108K Sell
56,923
-17,648
-24% -$30.3K ﹤0.01% 4254
2025
Q4 		$119K Buy
74,571
+73,000
+4,647% +$153K ﹤0.01% 4254
2025
Q3 		$3.66K Sell
1,571
-29,790
-95% -$56.2K ﹤0.01% 5324
2025
Q2 		$39.5K Sell
31,361
-32,558
-51% -$32K ﹤0.01% 4884
2025
Q1 		$58.4K Sell
63,919
-11,856
-16% -$15.4K ﹤0.01% 4836
2024
Q4 		$120K Buy
75,775
+4,400
+6% +$8.85K ﹤0.01% 4741
2024
Q3 		$140K Buy
71,375
+18,784
+36% +$38.5K ﹤0.01% 4592
2024
Q2 		$86.2K Sell
52,591
-416,929
-89% -$1.33M ﹤0.01% 4283
2024
Q1 		$2.41M Buy
469,520
+307,801
+190% +$1.9M ﹤0.01% 2287
2023
Q4 		$927K Sell
161,719
-59,447
-27% -$294K ﹤0.01% 2888
2023
Q3 		$1.06M Buy
221,166
+194,816
+739% +$1.21M ﹤0.01% 2465
2023
Q2 		$112K Sell
26,350
-169,345
-87% -$761K ﹤0.01% 4190
2023
Q1 		$1.04M Buy
195,695
+92,587
+90% +$577K ﹤0.01% 2519
2022
Q4 		$648K Sell
103,108
-25,516
-20% -$227K ﹤0.01% 2985
2022
Q3 		$1.36M Buy
128,624
+114,599
+817% +$1.07M ﹤0.01% 2470
2022
Q2 		$76K Sell
14,025
-8,464
-38% -$64.7K ﹤0.01% 4349
2022
Q1 		$206K Sell
22,489
-8,007
-26% -$84.4K ﹤0.01% 4062
2021
Q4 		$460K Buy
30,496
+28,271
+1,271% +$550K ﹤0.01% 3865
2021
Q3 		$53K Buy
+2,225
New +$54.4K ﹤0.01% 4707

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citigroup's CRBU Position: Q1 2026 in Review

Citigroup reduced its Caribou Biosciences (CRBU) stake by 24% in Q1 2026, selling an estimated $30.3K and leaving 56,923 shares worth $108K. The position accounts for ﹤0.01% of the portfolio, ranked #4254.

Citigroup first reported a position in CRBU in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.41M in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Citigroup held 56,923 shares of Caribou Biosciences worth $108K as of Q1 2026.
  • Citigroup sold 17,648 Caribou Biosciences shares in Q1 2026, an estimated $30.3K.
  • Caribou Biosciences made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4254 holding.
  • Citigroup first reported a position in Caribou Biosciences in Q3 2021 and has held it in 19 quarters since.
  • Citigroup's Caribou Biosciences position peaked at $2.41M in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.